Criteria for use of antiendotoxin monoclonal antibodies (HA-1A and E5) in adult and pediatric inpatients.
Shepherd
M F
MF
Department of Pharmacy, Abbott Northwestern Hospital, Minneapolis, MN.
D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002648:Child; D002675:Child, Preschool; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D007075:Immunoglobulin M; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007075:Immunoglobulin M; C071470:edobacomab; C068069:nebacumab